Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000985686 | SCV001134132 | pathogenic | not provided | 2018-10-30 | criteria provided, single submitter | clinical testing | The variant results in a shift of the reading frame, and is therefore predicted to significantly disrupt the protein structure. Found in at least one symptomatic patient, and not found in general population data. |
Johns Hopkins Genomics, |
RCV000576989 | SCV001167226 | pathogenic | Cystic fibrosis | 2019-10-04 | criteria provided, single submitter | clinical testing | This frameshift variant was previously identified in a patient with cystic fibrosis. It results in a premature stop codon in exon 18 (legacy exon 16) likely leading to nonsense-mediated decay and lack of protein production. In addition, this variant affects the first nucleotide of exon 18 and bioinformatic analysis predicts that it may affect normal exon 18 splicing, althougth this has not been confirmed experimentally to our knowledge. This CFTR variant is absent from large population datasets and a single submitter reports this variant in ClinVar, however, no classification is provided. We consider this variant to be pathogenic. |
Clin |
RCV000576989 | SCV000679417 | not provided | Cystic fibrosis | no assertion provided | literature only |